Collagen Solutions CEO Dr Stewart White chats with DirectorsTalk about being chosen to participate in a new research project to develop novel treatments for Parkinson’s disease.
Dr Stewart White was CEO of Collbio and has recent and direct board experience of an AIM quoted company. Stewart has international experience in operations, business and product development, and ‘Good Manufacturing Practices’ (GMP) compliant manufacturing of collagen medical devices, advanced biologics and Active Pharmaceutical Ingredients in both Small to Medium Enterprises as well as global pharmaceutical companies. Stewart is a graduate of the University of Strathclyde and holds a First Class degree in Applied Microbiology, a Ph.D. in Fermentation Technology and Bioprocessing and an MBA.
Collagen Solutions Plc was established and admitted to the London Stock Exchange on the 2nd January 2014 when Collbio Limited acquired the assets of Collagen Solutions LLC and went through a simultaneous reverse takeover under Rule 14 of the AIM Rules for Companies into Healthcare Investment Opportunities plc, which became Collagen Solutions Plc. On 10th December 2014, by way of reverse takeover, Collagen Solutions Plc, acquired Southern Lights Biomaterials based in New Zealand, being a logical strategic extension and complementary in nature to the Group’s existing business model.
Collagen Solutions plc provides customers with medical grade collagen products and development services to create collagen components from concept to clinical trial stage, including technology transfer and contract manufacturing.
